4.7 Review

Bile acid nuclear receptor FXR and digestive system diseases

Journal

ACTA PHARMACEUTICA SINICA B
Volume 5, Issue 2, Pages 135-144

Publisher

INST MATERIA MEDICA, CHINESE ACAD MEDICAL SCIENCES
DOI: 10.1016/j.apsb.2015.01.004

Keywords

Bile acids; Farnesoid X receptors; Gastrointestinal tract; Inflammatory bowel disease; Colorectal cancer; Type 2 diabetes

Funding

  1. National Cancer Institute of United States [1R01-CA139158]
  2. National Natural Science Foundation of China [81303186, ZYX-NSFC-016]
  3. China Postdoctoral Science Foundation [2013M531202]

Ask authors/readers for more resources

Bile acids (BAs) are not only digestive surfactants but also important cell signaling molecules, which stimulate several signaling pathways to regulate some important biological processes. The bile-acid-activated nuclear receptor, farnesoid X receptor (FXR), plays a pivotal role in regulating bile acid, lipid and glucose homeostasis as well as in regulating the inflammatory responses, harrier function and prevention of bacterial manslocation in the intestinal tract. As expected, FXR is involved in the pathophysiology of a wide, range of diseases of gastrointestinal tract, including inflammatory bowel disease, colorectal cancer and type 2 diabetes. In this review, we discuss current knowledge of the roles of FXR in physiology of the digestive system and the related diseases. Better understanding of the roles of FXR in digestive system will accelerate the development of FXR ligands/modulators for the treatment of digestive system diseases. (C) 2015 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. All rights reserved

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available